Silexion Therapeutics Statistics

Total Valuation

SLXN has a market cap or net worth of $1.15 million. The enterprise value is $728,236.

Market Cap	1.15M
Enterprise Value	728,236

Important Dates

The next estimated earnings date is Tuesday, August 11, 2026, before market open.

Earnings Date	Aug 11, 2026
Ex-Dividend Date	n/a

Share Statistics

SLXN has 418,995 shares outstanding.

Current Share Class	418,995
Shares Outstanding	418,995
Shares Change (YoY)	n/a
Shares Change (QoQ)	+2.67%
Owned by Insiders (%)	0.40%
Owned by Institutions (%)	4.53%
Float	414,619

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.21
P/TBV Ratio	3.96
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.00, with a Debt / Equity ratio of 6.84.

Current Ratio	1.00
Quick Ratio	0.59
Debt / Equity	6.84
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-6,365.50

Financial Efficiency

Return on equity (ROE) is -897.46% and return on invested capital (ROIC) is -190.63%.

Return on Equity (ROE)	-897.46%
Return on Assets (ROA)	-123.27%
Return on Invested Capital (ROIC)	-190.63%
Return on Capital Employed (ROCE)	-2,348.89%
Weighted Average Cost of Capital (WACC)	0.95%
Revenue Per Employee	n/a
Profits Per Employee	-$922,143
Employee Count	14
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, SLXN has paid $3,000 in taxes.

Income Tax	3,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -97.71% in the last 52 weeks. The beta is -0.33, so SLXN's price volatility has been lower than the market average.

Beta (5Y)	-0.33
52-Week Price Change	-97.71%
50-Day Moving Average	5.18
200-Day Moving Average	19.64
Relative Strength Index (RSI)	33.19
Average Volume (20 Days)	208,539

Short Selling Information

The latest short interest is 154,973, so 36.99% of the outstanding shares have been sold short.

Short Interest	154,973
Short Previous Month	159,027
Short % of Shares Out	36.99%
Short % of Float	37.38%
Short Ratio (days to cover)	0.10

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-12.73M
Pretax Income	-12.91M
Net Income	-12.91M
EBITDA	-12.72M
EBIT	-12.73M
Earnings Per Share (EPS)	-$63.78

Full Income Statement

Balance Sheet

The company has $2.41 million in cash and $1.99 million in debt, giving a net cash position of $424,000 or $1.01 per share.

Cash & Cash Equivalents	2.41M
Total Debt	1.99M
Net Cash	424,000
Net Cash Per Share	$1.01
Equity (Book Value)	291,000
Book Value Per Share	0.86
Working Capital	5,000

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$12.01 million and capital expenditures -$3,000, giving a free cash flow of -$12.02 million.

Operating Cash Flow	-12.01M
Capital Expenditures	-3,000
Depreciation & Amortization	12,000
Net Borrowing	n/a
Free Cash Flow	-12.02M
FCF Per Share	-$28.68

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SLXN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-1,120.43%
FCF Yield	-1,042.76%

Analyst Forecast

The average price target for SLXN is $60.00, which is 2,081.82% higher than the current price. The consensus rating is "Buy".

Price Target	$60.00
Price Target Difference	2,081.82%
Analyst Consensus	Buy
Analyst Count	2
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on May 29, 2026. It was a reverse split with a ratio of 1:10.

Last Split Date	May 29, 2026
Split Type	Reverse
Split Ratio	1:10

Scores

Altman Z-Score	n/a
Piotroski F-Score	2